Top 10 Holdings of Caligan Partners
Founded in 2017, Caligan Partners is one of the most significant specialty hedge funds.
Alimera Sciences Inc (ALIM)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Glazer Capital Paul Glazer | 0 | $0 | -100% | 0% |
| 2. | Millennium Management Israel Englander | 0 | $0 | -100% | 0% |
| 3. | Altium Capital Jacob Gottlieb | 0 | $0 | -100% | 0% |
| 4. | Velan Capital Adam Morgan | 0 | $0 | -100% | 0% |
| 5. | GAMCO Investors Mario Gabelli | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.39 | 579,000 | Large Shareholder | 16,835,154 | 2023-09-14 | Filing | |
| $1.70 | 1,401,901 | Large Shareholder, Director | 1,659,654 | 2023-05-17 | Filing | |
| $4.50 | 484 | Officer, Director | 110,518 | 2021-12-15 | Filing | |
| $4.80 | 5,000 | Officer, Director | 110,034 | 2021-12-03 | Filing | |
| $4.89 | 5,000 | Officer, Director | 105,034 | 2021-12-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.39 | 579,000 | Large Shareholder | 16,256,154 | 2023-09-14 | Filing | |
| $1.56 | 200,919 | 0 | 2023-03-24 | Filing | ||
| $4.55 | 250,000 | Large Shareholder | 557,551 | 2022-02-08 | Filing | |
| $9.62 | 45 | Officer | 19,379 | 2021-04-08 | Filing | |
| $6.73 | 5,000 | Director | 5,578 | 2020-08-20 | Filing |
Institutional Investors' Holdings
News See All
Alimera Sciences, Inc. (NASDAQ:ALIM) Q1 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good morning and welcome to the Alimera Sciences First Quarter and 2024 Financial Results and Corporate Update Conference Call.
Alimera Sciences, Inc. (NASDAQ:ALIM) Q4 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good morning and welcome to the Alimera Sciences Fourth Quarter and Fiscal Year 2023 Financial Results and Corporate Update Conference Call.
Alimera Sciences, Inc. (NASDAQ:ALIM) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good morning, and welcome to the Alimera Sciences Third Quarter 2022 [2023] (sic) Financial Results and Corporate Update Conference Call.
Alimera Sciences, Inc. (NASDAQ:ALIM) Q2 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good morning, and welcome to the Alimera Sciences Second Quarter 2023 Financial Results Conference Call. [Operator Instructions].
Alimera Sciences, Inc. (NASDAQ:ALIM) Q4 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good morning and welcome to the Alimera Sciences 2022 Financial Results Conference Call.
Alimera Sciences, Inc. (NASDAQ:ALIM) Q3 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good morning and welcome to the Alimera Sciences Third Quarter 2022 Financial Results and Corporate Update Conference Call.
10 Best Low Price Pharma Stocks To Buy Now
The global pharmaceuticals market was forecasted to grow from $1454.66 billion in 2021 to $1587.05 billion in 2022 at a compound annual growth rate (CAGR) of 9.1%.
Do Hedge Funds Love Alimera Sciences Inc (ALIM)?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Do Hedge Funds Love Alimera Sciences Inc (ALIM)?
In this article we will take a look at whether hedge funds think Alimera Sciences Inc (NASDAQ:ALIM) is a good investment right now.
Billionaire Hedge Funds
